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Background
Purpose of this study was to evaluate technical success,
complications and one year follow-up clinical success
for non-spinal painful osteoid osteomas treated with
MR-guided Focused Ultrasound (MRgFUS).
Materials and methods
This IRB approved prospective multicenter study was
performed between May 2010 and April 2012. Thirty
consecutive patients (M:21, F:9; Age range: 10-47; Mean
age: 25±16) have been enrolled at three different univer-
sity centers for non-spinal painful osteoid osteomas and
treated (29 lesions) using MRgFUS (3.0-T/1.5-T GE Dis-
covery MR 750/450, Milwaukee, USA equipped with
InSightec ExAblate 2100, Tirat Carmel, ISR). Lesions
were previously diagnosed on imaging basis, including
ce-dynamic MR (Gd-BOPTA, Bracco, Milan, Italy).
Mean number of sonications and energy deposition has
been recorded. Technical success was evaluated immedi-
ately after treatment for complications (skin burn, neu-
rovascular and tendon or ligament injuries). Twelve-
month observation period followed to evaluate clinical
success rate, recurrence and long-term complications.
Clinical success was determined on the basis of pain
reduction using visual analog scales (VAS); baseline and
post-treatment scores statistical difference was calcu-
lated (paired T-test).
Results
Twenty-nine non-spinal osteoid osteomas have been
successfully treated using MR-gFUS. Mean sonication
number was 7±3 and mean delivered acoustic energy
1180±736 J. At 12 month follow-up complete clinical
success was observed in 26 patients (26/29, 90%; Mean
VAS:0±0). Partial treatment was observed in 3 patients
(3/29, 10%; Mean VAS: 5±0), whom were treated in the
early phase of the learning curve and subsequently
underwent CT-gRFA (2/3) or open surgery (1/3). At
clinical evaluation, pain score values showed a signifi-
cant reduction (p<0.001) between baseline (Mean VAS:
8±1) and post-treatment (Mean VAS: 1±2). No compli-
cations have been observed during, immediately after
treatment and at one-year follow-up.
Conclusion
Results of this prospective multicenter study, suggest that
MR guided focused ultrasound may be considered an
effective and safe alternative approach in non-spinal
osteoid osteoma interventional management. Complete
clinical success rate of 90% was demonstrated without
adverse events.
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